Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
US11518747B2 · kind B2 · utility
4Cited by
36References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2022 |
| Grant date | Dec 6, 2022 |
| Priority date | — |
| Expiry date | Apr 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a crystalline form of Compound I, a salt, a solvate, or a solvate salt thereof or an amorphous form of Compound I, a salt, a solvate, or a solvate salt thereof. The present invention also provides compositions comprising the crystalline form and/or the amorphous form, therapeutic uses of the crystalline forms and/or the amorphous forms, and the compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.